Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Oncology Institute, Inc. (DFPH)
|
Add to portfolio |
|
|
|
| Price: |
$10.15
| | Metrics |
| OS: |
73.0
|
M
| |
-92
|
% ROE
|
| Market cap: |
$740
|
M
| |
-41
|
% ROIC
|
|
Net debt:
|
$4.16
|
M
| |
|
|
|
EV:
|
$745
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($61.2)
|
M
| |
|
|
|
EBIT
|
($66.2)
|
M
| |
|
|
| EPS |
($1.02)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 252.5 | 203.0 | 187.5 |
| Revenue growth | 24.4% | 8.3% | |
| Cost of goods sold | 200.4 | 33.1 | 150.6 |
| Gross profit | 52.1 | 169.9 | 36.9 |
| Gross margin | 20.6% | 83.7% | 19.7% |
| Selling, general and administrative | 119.7 | 83.4 | 41.9 |
| EBITA | -69.1 | -43.3 | -5.7 |
| EBITA margin | -27.4% | -21.4% | -3.0% |
| Amortization of intangibles | 2.9 | 2.5 | 2.5 |
| EBIT | -72.0 | -45.9 | -8.2 |
| EBIT margin | -28.5% | -22.6% | -4.4% |
| Pre-tax income | -0.1 | -11.6 | -14.8 |
| Income taxes | -0.2 | -0.7 | -0.5 |
| Tax rate | 267.0% | 5.8% | 3.3% |
| Net income | -17.0 | -10.6 | -14.3 |
| Net margin | -6.7% | -5.2% | -7.6% |
| |
| Diluted EPS | ($0.21) | ($0.16) | ($0.24) |
| Shares outstanding (diluted) | 80.6 | 66.2 | 59.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|